Interpretation of the updated “National Comprehensive Cancer Network Guidelines for non-small cell lung cancer ” (2019 V1 Ed.)

ZENG Da-xiong, HUANG Jian-an*

PDF(954 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(954 KB)
World Clinical Drug ›› 2019, Vol. 40 ›› Issue (01) : 1-5. DOI: 10.13683/j.wph.2019.01.001
Recommendation

Interpretation of the updated “National Comprehensive Cancer Network Guidelines for non-small cell lung cancer ” (2019 V1 Ed.)

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2019, 40(01): 1-5 https://doi.org/10.13683/j.wph.2019.01.001

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(954 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉